Show simple item record

dc.contributor.authorGulikers, Keven Peteren_US
dc.date.accessioned2014-03-14T20:33:52Z
dc.date.available2014-03-14T20:33:52Z
dc.date.issued2002-04-08en_US
dc.identifier.otheretd-04192002-163244en_US
dc.identifier.urihttp://hdl.handle.net/10919/31768
dc.description.abstractTricyclic antidepressants have been shown to alter thyroid function in man and laboratory animals, but have not been evaluated in the dog. The effect of administration of clomipramine on canine thyroid function was studied in a prospective protocol in which 14 mature, healthy dogs were administered clomipramine (3 mg/kg PO q12h) for 112 days. Thyroid-stimulating hormone (TSH), total thyroxine (T4), total 3,5,3' triiodothyronine (T3), free thyroxine (fT4), and 3,3',5' triiodothyronine (reverse T3; rT3) concentrations were measured on selected days. Thyrotropin-releasing hormone (TRH) response tests were performed concurrently. Repeated measures analysis of variance was applied to test for effects of day of treatment; when significance (p < 0.05) was noted, it was further investigated using orthogonal polynomial trends. Significant decreases were found in serum T4 (26 ± 1.2 to 17 ± 0.5 nmol/L, p < 0.001), fT4, (29 ± 2.4 to 19 ± 1.3 pmol/L, p < 0.0002), and rT3 (1.2 ± 0.1 to 0.83 ± 0.08 nmol/L, p < 0.0001) concentrations. The effect of time on serum T3 concentration was also significant (p < 0.0001), but no consistent trend could be identified. No significant effect of time was noted in either pre- or post-TRH TSH concentrations.

The results of this study indicate that significant and substantial decreases in T4 (35%), fT4 (38%), and rT3 can occur during clomipramine administration. Long-term administration of clomipramine may result in a misdiagnosis of hypothyroidism if a dog is tested while taking this medication and, since decreased serum fT4 occurs, hypothyroidism may result.

en_US
dc.publisherVirginia Techen_US
dc.relation.haspartThesis.pdfen_US
dc.rightsI hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to Virginia Tech or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.en_US
dc.subjectthyroxineen_US
dc.subjecttricyclic antidepressanten_US
dc.subjectthyroiden_US
dc.subjecthormoneen_US
dc.subjectclomipramineen_US
dc.subjectcanineen_US
dc.titleEvaluation of the effects of clomipramine on the canine hypothalamic-pituitary-thyroid axisen_US
dc.typeThesisen_US
dc.contributor.departmentVeterinary Medical Sciencesen_US
dc.description.degreeMaster of Scienceen_US
thesis.degree.nameMaster of Scienceen_US
thesis.degree.levelmastersen_US
thesis.degree.grantorVirginia Polytechnic Institute and State Universityen_US
thesis.degree.disciplineVeterinary Medical Sciencesen_US
dc.contributor.committeechairPanciera, David Lawrenceen_US
dc.contributor.committeememberWilcke, Jeffrey R.en_US
dc.contributor.committeememberMonroe, William Edwarden_US
dc.identifier.sourceurlhttp://scholar.lib.vt.edu/theses/available/etd-04192002-163244/en_US
dc.date.sdate2002-04-19en_US
dc.date.rdate2012-10-01
dc.date.adate2002-05-07en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record